GAL and neoplasm: Overall, studies with α-gal micelles in the pre-clinical model of anti-Gal producing GT-KO mice strongly suggested that injection of these micelles into solid tumors can convert them into in situ vaccines against TAs on the treated tumor cells, without the need for identifying the TAs.